References
- 1. Lemieux I., Total Cholesterol/HDL cholesterol ratio vs. LDL cholesterol/HDL cholesterol ratio as indices of ischaemic heart disease risk in men- The Quebec Cardiovascular Study, Arch Intern Med/Vol 161, Dec 10/24, 2001, 2685-1692.
- 2. Cui Y, Blumenthal RS, Flaws JA, et al. Non-highdensity lipo-protein cholesterol level as a predictor ofcardiovascular disease mortality. Arch Intern Med2001;161:1413-1419.
- 3. Bittner V, Hardison R, Kelsey SF et al. Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 2002;106:2537-2542.
- 4. Ridker PM, Rifai N, Cook NR et al. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as riskfactors for cardiovascular disease in women. JAMA2005;294:326-333.
- 5. Jeppesen J, Facchini FS, Reaven GM. Individuals with high total cholesterol/HDL cholesterol ratios are insulinresistant. J Intern Med 1998;243:293-298.
- 6. Ovbiagele B, Saver JL, Fredieu A, et al. PROTECT: a coordinated stroke treatment program to prevent recurrent thromboembolic events. Neurology 2004;63:1217-1222.
- 7. Smaha LA. The American Heart Association Get withthe Guidelines program. Am Heart J 2004;148:S46-S48.
- 8. Lee LJ, Kidwell CS, Alger J et al. Impacton stroke subtype diagnosis of early diffusionweightedmagnetic resonance imaging and magnetic resonance angiography. Stroke 2000;31:1081-1089.
- 9. Bianchi C, Penno G, Malloggi L, et al. Non-traditionalmarkers of atherosclerosis potentiate the risk of coronaryheart disease in patients with type 2 diabetes andmetabolic syndrome [published online ahead of printApril 7, 2007]. Nutr Metab Cardiovasc Dis.
- 10. Sumner AE, Finley KB, Genovese DJ et al. Fasting triglyceride and the triglyceride-HDL cholesterolratio are not markers of insulin resistance in AfricanAmericans. Arch Intern Med 2005;165:1395-1400.
- 11. Mecham RP. Overview of extracellular matrix. Curr Protoc Cell Biol. 2012 Dec;Chapter 10:Unit 10.1. doi: 10.1002/0471143030.cb1001s57.
- 12. Steven R. Van Doren. Matrix metalloproteinase interactions with collagen and elastin, Matrix Biol. 2015, 44-46, 224-231.
- 13. Nicoloff G, Petrova Ch, Christova P, Nikolov A. Detection of free elastin-derived peptides among diabetic children. Atherosclerosis 2007, 192;342-347.
- 14. Baydanoff S, Nicoloff G, Alexiev Ch. Age-related changes in anti-elastin antibodies inserum from normal and atherosclerotic human subjects Atherosclerosis 1987;63:267-71.
- 15. Fulop T, Wei S, Robert L, Jacob MP. Determination of elastin peptides in normal andatherosclerotic human sera by ELISA Clin Physiol Biochem 1990;08:273-8.
- 16. Colburn K, Langga-Shariffi E, Kelly G, et al. Abnormalities of serum anti elastin Influence of elastin-derived peptides on metalloprotease production in endothelial cells. J. Investiq Med., 2003,51(2),104-9.
- 17. Siemianowicz K, Gminski J, Goss M et al. Influence of elastin-derived peptides on metalloprotease production in endothelial cells. Experimental and Therapeutic Medicine. 2010, 1(6):1057-1060.
- 18. Robert L, Molinari J, Ravelojaona V, Andrès E. Age- and passage-dependent upregulation of fibroblast elastase-type endopeptidase activity. Role of advanced glycation endproducts, inhibition by fucose, Archives of gerontology, 2010 – Elsevier.
- 19. Jimenez F, Mitts T, Hinek A. Elastin protective polyphenolics and methods of using the same US Patent 8,114,829, 2012 – Google Patents.
- 20. Fulop T, Wei S, Robert L, Jacob MP. Determination of elastin peptides in normal andatherosclerotic human sera by ELISA. Clin Physiol Biochem 1990;08:273-8.
- 21. Lazarovici P, Pomerantz C, Chen X, Wei Y. Co-electrospun blends of PLGA, gelatin, and elastin as potential nonthrombogenic scaffolds for vascular tissue engineering, 2010 – ACS Publications.
- 22. Gaziano JM, Hennekens CH, O’Donnell CJ et al. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation 1997;96:2520-2525.
- 23. Wakabayashi I, Associations of Blood Lipid-Related Indices with Blood Pressure and Pulse Pressure in Middle-Aged Men, Metab Syndr Relat Disord, 2015,31(1):22-8.
- 24. Kannel WB, Gordon T. Physiological and medical concomitants of obesity. The Framingham study. In: Bray G, ed. Obesity in America. Betesda, MD: US Department of Health, education and welfare, Public Health, Health service, National institutes of Health; 1979; 125-163.
- 25. Spiegelberg H. Immunoglobulins. In: Inflammation: Basic Principles and Clinical Correlates (Edited. by Gallin, J. and Goldstein, I.) Raven Press; New York, 1988,11-19.
- 26. Peterszegi G, Mandet C, Texier S et al. Lymphocytes in human atherosclerotic plaque exhibit the elastin-laminin receptor: potential role in atherogenesis. Atheroscl 1997a;135:103-107.
- 27. Peterszegi G, Texier S, Robert L. Human helper and memory lymphocytes exhibit an inducible elastin-laminin receptor. Intl Arch Immunol 1997b;114,:218-223.
- 28. Mestecky J, McGhee JR. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA byosynthesis and immune response. Adv Immunol 1987;40:153-245.
- 29. Mestecky J. Interaction of lymphoid cells with epithelial cells: selectivity of the expression of IgA in mucosal plasma cells and of the transport of polymeric IgA. In: Monographs in Allergy (Edited by Dukor, P, Shakib, F, Trunka, Z, Waksman, BH) S. Karger, Basel, 1988,83-90.
- 30. Podet EJ, Shaffer DR, Gianturco SH, et al. Interaction of low density lipoproteins with human aortic elastin. Atheroscler Thromb 1991;11:116-122. 25.
- 31. Taskinen MR. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia, 2003;46:733-749.
- 32. Kennedy L. Glycation of immunoglobulins and serumproteins. Diabetologia, 2003;46:733-749.27.
- 33. Singh R, Barden A, Mori T, Beilin L (2001)Advanced glycation end-products: a review. Diabetologia, 44: 129-146.